Gene · 4838
Papers4,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering a computable epiblast for in silico modeling of developmental toxicity. | Reprod Toxicol | 2024 | 38857815 | PubTator, text mining | PubMed |
NANOG regulate the JAK/STAT3 pathway to promote trophoblast cell migration and epithelial-mesenchymal transition (EMT) in hypertensive disorders of pregnancy (HDP) through protein interaction with CDK1. | Am J Reprod Immunol | 2024 | 38796740 | PubTator, text mining | PubMed |
| TBX3 transfection and nodal signal pathway inhibition promote differentiation of adipose mesenchymal stem cell to cardiac pacemaker-like cells. | Stem Cell Res Ther | 2024 | 38778426 | PubTator, text mining | PubMed |
| Subtype and Lineage-Mediated Protocol for Standardizing Activin/Nodal and BMP Signaling for hiPSC-Derived Cardiomyocyte Differentiation. | Methods Mol Biol | 2024 | 38676882 | PubTator, text mining | PubMed |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Cells | 2024 | 38667322 | PubTator, text mining | PubMed |
| The Role of Sentinel Lymph Node Biopsy in the Management of Merkel Cell Carcinoma: A Systematic Review and Meta-analysis. | Plast Reconstr Surg Glob Open | 2024 | 38645636 | PubTator, text mining | PubMed |
| Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping. | J Pharm Anal | 2024 | 38618242 | PubTator, text mining | PubMed |
| Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ. | Cancer Res | 2024 | 38616659 | PubTator, text mining | PubMed |
| A novel NODAL variant in a young embolic stroke patient with visceral heterotaxy. | BMC Neurol | 2024 | 38605286 | PubTator, text mining | PubMed |
| Nodal negatively regulates osteoclast differentiation by inducing STAT1 phosphorylation. | J Cell Physiol | 2024 | 38577903 | PubTator, text mining | PubMed |
| NODAL variants are associated with a continuum of laterality defects from simple D-transposition of the great arteries to heterotaxy. | Genome Med | 2024 | 38570875 | PubTator, text mining | PubMed |
| Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signaling. | J Biol Chem | 2024 | 38569937 | PubTator, text mining | PubMed |
| Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland. | J Med Screen | 2024 | 38509806 | PubTator, text mining | PubMed |
| Using Embryo Models to Understand the Development and Progression of Embryonic Lineages: A Focus on Primordial Germ Cell Development. | Cells Tissues Organs | 2024 | 38479364 | PubTator, text mining | PubMed |
| Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy. | Int J Mol Sci | 2024 | 38473926 | PubTator, text mining | PubMed |
| VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling. | World J Stem Cells | 2024 | 38455101 | PubTator, text mining | PubMed |
| Responses in the left and right entopallium are differently affected by light stimulation in embryo. | iScience | 2024 | 38439979 | PubTator, text mining | PubMed |
| R-Spondin 2 governs Xenopus left-right body axis formation by establishing an FGF signaling gradient. | Nat Commun | 2024 | 38307837 | PubTator, text mining | PubMed |
| The clinical utilization of SNIP1 and its pathophysiological mechanisms in disease. | Heliyon | 2024 | 38304835 | PubTator, text mining | PubMed |
| Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study. | Ann Surg Oncol | 2024 | 38300405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4838/papers?page=11